- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BG00002 (natalizumab)
Total 180 results
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany, United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCzechia, Belgium
-
BiogenTerminated
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Puerto Rico
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisIreland
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
BiogenElan PharmaceuticalsCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompleted
-
BiogenTerminatedRelapsing Multiple SclerosisBelgium
-
BiogenTerminatedCrohn's DiseaseUnited States, Puerto Rico
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
BiogenElan Pharmaceuticals; United BioSource, LLCCompleted
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisJapan
-
BiogenCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Germany, Belgium
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenActive, not recruiting
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
BiogenElan PharmaceuticalsCompleted
-
BiogenTerminatedMultiple Sclerosis, Relapsing-RemittingGermany
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisRussian Federation
-
BiogenCompletedProgressive Multifocal LeukoencephalopathyUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
BiogenElan PharmaceuticalsCompletedMultiple SclerosisUnited States
-
BiogenCompleted
-
BiogenRecruitingMultiple SclerosisUnited States, Germany
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
BiogenElan PharmaceuticalsWithdrawn
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompleted
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, United Kingdom
-
University at BuffaloCompleted
-
University Hospital, CaenBiogenCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of South FloridaCompletedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, Canada
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
BiogenElan PharmaceuticalsTerminated